Viewing StudyNCT00095381

Bugs

eRecord

Ignite Creation Date: 2024-05-05 @ 11:37 AM

Last Modification Date: 2024-10-26 @ 9:11 AM

Study NCT ID: NCT00095381

Status: COMPLETED

Last Update Posted: 2012-01-19

First Post: 2004-11-03

Brief Title: Repeat-Dose of Forodesine Hydrochloride BCX-1777 Infusion in Patients With Advanced T-Cell Leukemia

Sponsor: BioCryst Pharmaceuticals

Organization: BioCryst Pharmaceuticals

Overview Dates Organization Conditions Design Enrollment Locations Outcomes

Conditions:

Name

Leukemia T-Cell

Keywords:

Name	View

Leukemia Lymphocytic T-Cell	View
Entry Term Lymphocytic Leukemia T-Cell	View
T-Cell Leukemia	View
T-Lymphocytic Leukemia	View
Leukemia Lymphocytic T Cell	View
T Lymphocytic Leukemia	View
BCX-1777	View
forodesine hydrochloride	View
BioCryst	View